EROS: Engendering Reproductive Health within Oncologic Survivorship (E1Q11)

For a patient to be eligible for participation in this study, all of the following criteria must apply.

• Female patients presenting with initial diagnosis of any type of cancer (up to 3 months after diagnosis, and if applicable, before initiation of chemotherapy or radiation)
• Pre-menopausal patients within the reproductive age range
• Pregnant women are eligible to participate in this study
• Patients must have the cognitive ability to participate in the study
• Patients must not have had a prior hysterectomy, bilateral oophorectomy or sterilization of any method (including partner sterilization)

To learn more, visit ClinicalTrials.Gov

Study Type

Interventional

Principal Investigator(s)

Amanda Hathaway, MD

Sponsor(s)

Eastern Cooperative Oncology Group